Immunologix's Seed VC Round

Immunologix raised a round of funding on March 19, 2010. Investors include SCRA MUSC Innovation Center.

Immunologix is a human antibody development company founded on a proprietary technology that transforms naive B-cells into fully human monoclonal antibodies targeting any antigen. In October 2011, Im…

Articles about Immunologix's Seed VC Round: